Radiopharm Theranostics Limited Finance Costs
Radiopharm Theranostics Limited (RADX) reported Finance Costs of $65.30 thousand for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2025-09-18
| Period end | Finance Costs 12 month |
|---|---|
| 2025-06-30 | $65.30K 20-F · filed 2025-09-18 |
| 2024-06-30 | $642.89K 20-F · filed 2025-09-18 |
| 2023-06-30 | $86.09K 20-F · filed 2025-09-18 |